FDA Adverse Event Injury Summary report: N

EMBOSHIELD NAV6 EMBOLIC PROTECTION SYSTEM

MDR report key: 1905850 · Received November 23, 2010

Report

Report Number
3004742046-2010-00552
Event Type
Injury
Date Received
November 23, 2010
Date of Event
October 29, 2010
Report Date
October 29, 2010
Manufacturer
AV-TEMECULA
Product Code
NTE
PMA / PMN Number
K090665
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MS, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

(B)(4): DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE EVENT, PATIENT AND DEVICE INFORMATION. STROKE MAY OCCUR DURING THIS TYPE OF PROCEDURE AND AS LISTED IN THE INSTRUCTIONS FOR USE, IS A KNOWN POTENTIAL ADVERSE EVENTS ASSOCIATED WITH THE USE OF THE PRODUCT. THE REPORTED HOSPITALIZATION WAS IN RESPONSE TO THE PATIENT SYMPTOMS. THERE WAS NO DEVICE MALFUNCTION REPORTED THAT COULD HAVE CONTRIBUTED TO THE EVENT. INFORMATION AVAILABLE IN THE CASE DESCRIPTION IS NOT SUFFICIENT TO DETERMINE A RELATIONSHIP BETWEEN THE EVENT AND THE ABBOTT VASCULAR PRODUCT. BASED ON AVAILABLE INFORMATION, A DEFINITIVE CAUSE FOR THE REPORTED PATIENT ADVERSE EFFECTS AND THE RELATIONSHIP TO THE PRODUCT, IF ANY, CANNOT BE DETERMINED, HOWEVER, THERE WAS NO INDICATION OF ANY PRODUCT DEFICIENCIES WHICH COULD HAVE CONTRIBUTED TO THE OUTCOME OF THE PROCEDURE.

Description of Event or Problem · 1

IT WAS REPORTED THAT DURING THE PROCEDURE IN THE RIGHT INTERNAL CAROTID ARTERY, THE PATIENT EXPERIENCED A CEREBROVASCULAR ACCIDENT (CVA) WITH LEFT SIDED WEAKNESS AND INATTENTION, SENSORY LOSS, HEMIANOPIA, APHASIA AND DYSARTHRIA. CT SCAN REVEALED EVOLVING RIGHT MIDDLE CEREBRAL ARTERY CVA. THE PATIENT WAS DISCHARGED TO A REHABILITATION FACILITY ON (B)(6) 2010. THE NEUROLOGIC SYMPTOMS IMPROVED ALTHOUGH DEFICITS CONTINUE. THOUGH REQUESTED NO ADDITIONAL INFORMATION WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 EMBOSHIELD NAV6 EMBOLIC PROTECTION SYSTEM EMBOLIC PROTECTION SYSTEM NTE AV-TEMECULA 0081951

Patients

Seq Age Sex Outcome Treatment
1 68 YR Hospitalization| S